All companies › BLZE

BLZE · Backblaze, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells2
Research cases0
Last filing2026-08-21

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-21 — Suidan Marc · sold 2,110 @ $15.82 2026-08-21 — Budman Gleb · sold 12,855 @ $15.82
2026-08-212026-08-21

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Suidan Marc Chief Financial Officer
Budman Gleb CEO and Chairperson, Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $BLZE is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-08-21', 'insider_name': 'Suidan Marc', 'insider_title': 'Chief Financial Officer', 'transaction_type': 'Open-market sell', 'shares': 2110.0, 'price': 15.82, 'value': 33380.2, 'is_buy': False}, {'transaction_date': '2026-08-21', 'insider_name': 'Budman Gleb', 'insider_title': 'CEO and Chairperson, Director', 'transaction_type': 'Open-market sell', 'shares': 12855.0, 'price': 15.82, 'value': 203366.1, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for BLZE today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.